已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Recurrent Pulmonary Tuberculosis in China, 2005 to 2021

医学 肺结核 回顾性队列研究 儿科 内科学 队列 肺结核 疾病 病理
作者
Tao Li,Bo Zhang,Xin Du,Shaojun Pei,Zhongwei Jia,Yanlin Zhao
出处
期刊:JAMA network open [American Medical Association]
卷期号:7 (8): e2427266-e2427266 被引量:4
标识
DOI:10.1001/jamanetworkopen.2024.27266
摘要

Importance Despite posing a significant challenge to global tuberculosis (TB) elimination efforts, recurrent TB remains understudied due to the challenges of long-term observation. Objective To investigate the burden of recurrent TB using data from patients with pulmonary TB (PTB) in China. Design, Setting, and Participants This retrospective cohort study included all bacteriologically confirmed or clinically diagnosed PTB cases reported to the Tuberculosis Information Management System with completed or successful treatment outcomes from January 1, 2005, to December 31, 2021. Data were analyzed from July 15, 2022, to October 28, 2023. Exposures Newly diagnosed PTB was classified into primary, hematogenous disseminated, or secondary PTB. Main Outcomes and Measures The primary outcome was the annual recurrence rate, stratified by disease classification, over the 17-year observation period. The recurrence rate for year n was calculated by dividing the number of patients with recurrent TB in year n by observed person-years in year n . The secondary outcome was the annual proportion of recurrent TB among reported cases and associated risk factors. Results Of 13 833 249 patients with TB reported to the Tuberculosis Information Management System, 10 482 271 with PTB met the inclusion criteria. Of these, 68.9% were male, 22.3% were 65 years or older, 89.6% were of Han ethnicity, and 68.4% were agricultural workers. A total of 413 936 patients experienced a recurrent TB episode after successful treatment, resulting in an overall recurrence rate of 0.47 (95% CI, 0.47-0.48) per 100 person-years. The recurrence rate for patients with primary PTB was 0.24 (95% CI, 0.22-0.26) per 100 person-years; for hematogenous disseminated PTB, 0.37 (95% CI, 0.36-0.38) per 100 person-years; and for secondary PTB, 0.48 (95% CI, 0.47-0.48) per 100 person-years. The cumulative proportion of recurrences within the first 2 years accounted for 48.9% of all recurrent cases. The proportion of recurrent cases among notified incident cases increased 1.9-fold from 4.7% in 2015 to 8.8% in 2021. Among other factors, ages 45 to 64 years (adjusted hazard ratio, 1.77 [95% CI, 1.65-1.89]) and having completed treatment (adjusted hazard ratio, 1.16 [95% CI, 1.14-1.18]) were identified as associated with recurrence. Conclusions and Relevance In this retrospective cohort study, the PTB recurrence rate was substantially higher than the incidence, and the proportion of recurrent cases increased. Almost half of the recurrence occurred within the first 2 years, suggesting that routine posttreatment follow-up may represent an important strategy for accelerating TB elimination.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Akim应助hume采纳,获得10
4秒前
yuan完成签到 ,获得积分10
11秒前
akakns完成签到 ,获得积分10
21秒前
罐罐完成签到,获得积分10
23秒前
六六完成签到 ,获得积分10
27秒前
28秒前
30秒前
直觉应助科研达人采纳,获得10
31秒前
Cain完成签到,获得积分10
31秒前
叮当拉卡给叮当拉卡的求助进行了留言
33秒前
和谐的冬莲完成签到 ,获得积分10
33秒前
Li发布了新的文献求助10
35秒前
水若琳发布了新的文献求助10
35秒前
隐形曼青应助背后的鞋垫采纳,获得10
38秒前
lab完成签到 ,获得积分0
42秒前
wch666完成签到,获得积分10
42秒前
GingerF完成签到,获得积分0
47秒前
NZC完成签到,获得积分10
48秒前
luroa完成签到 ,获得积分10
50秒前
英俊的铭应助风吹屁屁凉采纳,获得10
52秒前
科研通AI2S应助科研通管家采纳,获得10
53秒前
科目三应助wch666采纳,获得10
53秒前
轻语完成签到 ,获得积分10
57秒前
张建威完成签到,获得积分10
1分钟前
bkagyin应助小刘采纳,获得10
1分钟前
1分钟前
调皮的灰狼完成签到,获得积分10
1分钟前
1分钟前
litieniu发布了新的文献求助10
1分钟前
1分钟前
感谢有你完成签到 ,获得积分10
1分钟前
1分钟前
CodeCraft应助科研达人采纳,获得10
1分钟前
1分钟前
小刘发布了新的文献求助10
1分钟前
1分钟前
dou完成签到 ,获得积分10
1分钟前
默默完成签到,获得积分10
1分钟前
1分钟前
风吹屁屁凉完成签到,获得积分10
1分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990008
求助须知:如何正确求助?哪些是违规求助? 3532034
关于积分的说明 11256121
捐赠科研通 3270913
什么是DOI,文献DOI怎么找? 1805105
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809216